Literature DB >> 14973

Postsynthetic deamidation of hemoglobin Providence (beta 82 Lys replaced by Asn, Asp) and its effect on oxygen transport.

S Charache, J Fox, P McCurdy, H Kazazian, R Winslow, P Hathaway, R van Beneden, M Jessop.   

Abstract

Carriers of hemoglobin Providence have three types of beta chain in their hemolysates. The two abnormal chains have asparagine (Providence N, Prov N) or aspartic acid (Providence D) at position beta 82, instead of lysine. In vitro, only two beta chains are synthesized by reticulocytes of carriers, betaA and betaProv N. In vivo studies showed that the specific activity of Providence N was initially 10-fold higher than that of Providence D; the specific activities of the two labeled hemoglobins were approximately equal 5 wk after injection of isotope. Oxygen affinity of carriers' blood was somewhat increased, but they were not polycythemic. The affinity of the purified hemoglobins Providence was decreased. Addition of 2, 3 diphosphoglycerate had little effect on the affinity of either hemoglobin component, and addition of inositol hexaphosphate produced no change in the affinity of Providence D. These studies demonstrate that Providence N is deamidated to Providence D during the life span of the erythrocyte, and suggest this finding may represent only an easily observed prototype of posttranslational modification of proteins in general. Despite and abnormal P50 of the blood, oxygen transport is probably normal in carriers of the abnormal hemoglobins.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 14973      PMCID: PMC372269          DOI: 10.1172/JCI108683

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  HEMOGLOBIN J (BALTIMORE) COEXISTING IN A FAMILY WITH HEMOGLOBIN S.

Authors:  D J WEATHERALL
Journal:  Bull Johns Hopkins Hosp       Date:  1964-01

2.  Hemoglobin J.

Authors:  O A THORUP; H A ITANO; M WHEBY; B S LEAVELL
Journal:  Science       Date:  1956-05-18       Impact factor: 47.728

3.  Hemoglobin Richmond. Subunit dissociation and oxygen equilibrium properties.

Authors:  R M Winslow; S Charache
Journal:  J Biol Chem       Date:  1975-09-10       Impact factor: 5.157

4.  Haemoglobin Rahere (beta Lys-Thr): A new high affinity haemoglobin associated with decreased 2, 3-diphosphoglycerate binding and relative polycythaemia.

Authors:  P A Lorkin; A D Stephens; M E Beard; P F Wrigley; L Adams; H Lehmann
Journal:  Br Med J       Date:  1975-10-25

Review 5.  Deamidation of glutaminyl and asparaginyl residues in peptides and proteins.

Authors:  A B Robinson; C J Rudd
Journal:  Curr Top Cell Regul       Date:  1974

Review 6.  Various aspects of alpha-thalassemia.

Authors:  H Lehmann; A Lang
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

7.  Abnormal globin synthesis in thalassemic red cells.

Authors:  E Schwartz
Journal:  Semin Hematol       Date:  1974-10       Impact factor: 3.851

8.  An enzymic reduction system for metmyoglobin and methemoglobin, and its application to functional studies of oxygen carriers.

Authors:  A Hayashi; T Suzuki; M Shin
Journal:  Biochim Biophys Acta       Date:  1973-06-15

9.  Hemoglobin Providence. A human hemoglobin variant occurring in two forms in vivo.

Authors:  W F Moo-Penn; D L Jue; K C Bechtel; M H Johnson; R M Schmidt
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

10.  Synthesis of hemoglobin AIc in normal and diabetic mice: potential model of basement membrane thickening.

Authors:  R J Koenig; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

View more
  9 in total

Review 1.  Stability of protein pharmaceuticals.

Authors:  M C Manning; K Patel; R T Borchardt
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

2.  Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex.

Authors:  S Charache; G Dover; K Smith; C C Talbot; M Moyer; S Boyer
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

3.  Chemical pathways of peptide degradation. I. Deamidation of adrenocorticotropic hormone.

Authors:  N P Bhatt; K Patel; R T Borchardt
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

4.  The Separation and Quantitation of Peptides with and without Oxidation of Methionine and Deamidation of Asparagine Using Hydrophilic Interaction Liquid Chromatography with Mass Spectrometry (HILIC-MS).

Authors:  Majors J Badgett; Barry Boyes; Ron Orlando
Journal:  J Am Soc Mass Spectrom       Date:  2017-01-03       Impact factor: 3.109

Review 5.  Hemoglobin variants: biochemical properties and clinical correlates.

Authors:  Christopher S Thom; Claire F Dickson; David A Gell; Mitchell J Weiss
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

6.  An 18O-labeling assisted LC/MS method for assignment of aspartyl/isoaspartyl products from Asn deamidation and Asp isomerization in proteins.

Authors:  Shunhai Wang; Igor A Kaltashov
Journal:  Anal Chem       Date:  2013-06-13       Impact factor: 6.986

7.  'GPI Roma', a new glucose phosphate isomerase deficient variant: in vivo occurrence of postsynthetic modifications of the mutant enzyme.

Authors:  G Isacchi; D Cottreau; F Mandelli; G Papa; F Ciccone; A Kahn
Journal:  Hum Genet       Date:  1979-01-25       Impact factor: 4.132

8.  Hemoglobin Providence (β82 Lys > Asn, Asp) and lower-than-expected HbA1c in a nonadherent teenager with type 1 diabetes: a case report and literature review.

Authors:  Charles N Newman; Christine M Litwin; Deborah A Bowlby; Katherine A Lewis; Remberto C Paulo
Journal:  Clin Case Rep       Date:  2017-10-30

9.  The Providence Mutation (βK82D) in Human Hemoglobin Substantially Reduces βCysteine 93 Oxidation and Oxidative Stress in Endothelial Cells.

Authors:  Sirsendu Jana; Michael Brad Strader; Abdu I Alayash
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.